Treatment of Moderate to Severe Plaque Psoriasis
Clinical trial NCT06542614 · COMPLETED
Trial details
- NCT number
- NCT06542614
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-27
- Primary completion
- 2025-11-03
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.